OS Therapies Reports Full Year 2024 Financial Results and Provides Business Update
OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today reported full-year 2024 financial ...
OS Therapies Provides Regulatory Update on Rare Pediatric Cancer Immunotherapy Candidate OST-HER2 for Human Osteosarcoma
OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today provided a regulatory update for its ...
Xenetic: PeriNess in XBIO-015 study to treat osteosarcoma and Ewing sarcoma
Biosciences, announced that its collaboration partner, PeriNess has entered into a Clinical Study Agreement to support an ...
Xenetic partner PeriNess enters clinical study agreement for XBIO-015
Biosciences’ collaboration partner, PeriNess has entered into a Clinical Study Agreement to support an exploratory clinical ...
OS Therapies (OSTX): Among the Penny Stocks With Huge Upside Potential According to Analysts
We recently published a list of 10 Penny Stocks With Huge Upside Potential According To Analysts. In this article, we are ...
BioSpace19d
OS Therapies Awarded OST-HER2 Clinical Trial Data Presentation at MIB Agents FACTOR Osteosarcoma Conference
Key data will be presented from the Company’s Phase 2b clinical trial of OST-HER2 in the prevention of recurrent, fully resected, lung metastatic osteosarcoma. This data will be compared with a newly ...
Business Wire20d
OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency's (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its ...
About OS Therapies OS Therapies is a clinical stage oncology company focused on the identification, development, and commercialization of treatments for Osteosarcoma (OS) and other solid tumors.
KRIV26d
What is Osteosarcoma?
Turner was elected to serve Texas' 18th Congressional in November 2024. Turner was diagnosed with Osteosarcoma, a form of bone cancer, in 2022. HOUSTON - Congressman and former Houston Mayor Sylvester ...